FBN-1, a fibrillin-related protein, is required for resistance of the epidermis to mechanical deformation during C. elegans embryogenesis

  1. Melissa Kelley
  2. John Yochem
  3. Michael Krieg
  4. Andrea Calixto
  5. Maxwell G Heiman
  6. Aleksandra Kuzmanov
  7. Vijaykumar Meli
  8. Martin Chalfie
  9. Miriam B Goodman
  10. Shai Shaham
  11. Alison Frand
  12. David S Fay  Is a corresponding author
  1. University of Wyoming, United States
  2. Stanford University, United States
  3. Columbia University, United States
  4. Boston Children's Hospital, United States
  5. University of California, United States
  6. Standford University, United States
  7. The Rockefeller University, United States

Abstract

During development, biomechanical forces contour the body and provide shape to internal organs. Using genetic and molecular approaches in combination with a FRET-based tension sensor, we characterized a pulling force exerted by the elongating pharynx (foregut) on the anterior epidermis during C. elegans embryogenesis. Resistance of the epidermis to this force and to actomyosin-based circumferential constricting forces is mediated by FBN-1, a ZP domain protein related to vertebrate fibrillins. fbn-1 was required specifically within the epidermis and FBN-1 was expressed in epidermal cells and secreted to the apical surface as a putative component of the embryonic sheath. Tiling array studies indicated that fbn-1 mRNA processing requires the conserved alternative splicing factor MEC-8/RBPMS. The conserved SYM-3/FAM102A and SYM-4/WDR44 proteins, which are linked to protein trafficking, function as additional components of this network. Our studies demonstrate the importance of the apical extracellular matrix in preventing mechanical deformation of the epidermis during development.

Article and author information

Author details

  1. Melissa Kelley

    Department of Molecular Biology, University of Wyoming, Laramie, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. John Yochem

    Department of Molecular Biology, University of Wyoming, Laramie, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Michael Krieg

    Department of Molecular and Cellular Physiology, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Andrea Calixto

    Department of Biological Sciences, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Maxwell G Heiman

    Department of Genetics, Harvard Medical School, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Aleksandra Kuzmanov

    Department of Molecular Biology, University of Wyoming, Laramie, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Vijaykumar Meli

    Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Martin Chalfie

    Department of Biological Sciences, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Miriam B Goodman

    Department of Molecular and Cellular Physiology, Standford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Shai Shaham

    Laboratory of Developmental Genetics, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Alison Frand

    Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. David S Fay

    Department of Molecular Biology, University of Wyoming, Laramie, United States
    For correspondence
    davidfay@uwyo.edu
    Competing interests
    The authors declare that no competing interests exist.

Copyright

© 2015, Kelley et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,023
    views
  • 634
    downloads
  • 55
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Melissa Kelley
  2. John Yochem
  3. Michael Krieg
  4. Andrea Calixto
  5. Maxwell G Heiman
  6. Aleksandra Kuzmanov
  7. Vijaykumar Meli
  8. Martin Chalfie
  9. Miriam B Goodman
  10. Shai Shaham
  11. Alison Frand
  12. David S Fay
(2015)
FBN-1, a fibrillin-related protein, is required for resistance of the epidermis to mechanical deformation during C. elegans embryogenesis
eLife 4:e06565.
https://doi.org/10.7554/eLife.06565

Share this article

https://doi.org/10.7554/eLife.06565

Further reading

    1. Cell Biology
    Kaima Tsukada, Rikiya Imamura ... Mikio Shimada
    Research Article

    Polynucleotide kinase phosphatase (PNKP) has enzymatic activities as 3′-phosphatase and 5′-kinase of DNA ends to promote DNA ligation and repair. Here, we show that cyclin-dependent kinases (CDKs) regulate the phosphorylation of threonine 118 (T118) in PNKP. This phosphorylation allows recruitment to the gapped DNA structure found in single-strand DNA (ssDNA) nicks and/or gaps between Okazaki fragments (OFs) during DNA replication. T118A (alanine)-substituted PNKP-expressing cells exhibited an accumulation of ssDNA gaps in S phase and accelerated replication fork progression. Furthermore, PNKP is involved in poly (ADP-ribose) polymerase 1 (PARP1)-dependent replication gap filling as part of a backup pathway in the absence of OFs ligation. Altogether, our data suggest that CDK-mediated PNKP phosphorylation at T118 is important for its recruitment to ssDNA gaps to proceed with OFs ligation and its backup repairs via the gap-filling pathway to maintain genome stability.

    1. Cell Biology
    2. Neuroscience
    Vibhavari Aysha Bansal, Jia Min Tan ... Toh Hean Ch'ng
    Research Article

    The emergence of Aβ pathology is one of the hallmarks of Alzheimer’s disease (AD), but the mechanisms and impact of Aβ in progression of the disease is unclear. The nuclear pore complex (NPC) is a multi-protein assembly in mammalian cells that regulates movement of macromolecules across the nuclear envelope; its function is shown to undergo age-dependent decline during normal aging and is also impaired in multiple neurodegenerative disorders. Yet not much is known about the impact of Aβ on NPC function in neurons. Here, we examined NPC and nucleoporin (NUP) distribution and nucleocytoplasmic transport using a mouse model of AD (AppNL-G-F/NL-G-F) that expresses Aβ in young animals. Our studies revealed that a time-dependent accumulation of intracellular Aβ corresponded with a reduction of NPCs and NUPs in the nuclear envelope which resulted in the degradation of the permeability barrier and inefficient segregation of nucleocytoplasmic proteins, and active transport. As a result of the NPC dysfunction App KI neurons become more vulnerable to inflammation-induced necroptosis – a programmed cell death pathway where the core components are activated via phosphorylation through nucleocytoplasmic shutting. Collectively, our data implicates Aβ in progressive impairment of nuclear pore function and further confirms that the protein complex is vulnerable to disruption in various neurodegenerative diseases and is a potential therapeutic target.